Furthermore, THRB is not co-expressed with other NHRs (Fig. 7a), suggesting that THRB expression could be used to categorize patients into novel clinically-relevant subgroups, much like the molecular expression profiling (e.g. OncotypeDx) used in breast tumors to determine whether a patient’s tumor is likely to recur [45]. This evidence concerns the gene THRB and breast neoplasm.